JP2008540366A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008540366A5 JP2008540366A5 JP2008509408A JP2008509408A JP2008540366A5 JP 2008540366 A5 JP2008540366 A5 JP 2008540366A5 JP 2008509408 A JP2008509408 A JP 2008509408A JP 2008509408 A JP2008509408 A JP 2008509408A JP 2008540366 A5 JP2008540366 A5 JP 2008540366A5
- Authority
- JP
- Japan
- Prior art keywords
- tiotropium bromide
- solvate
- crystalline
- dried
- crystalline tiotropium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67680705P | 2005-05-02 | 2005-05-02 | |
| US60/676,807 | 2005-05-02 | ||
| PCT/EP2006/061763 WO2006117299A2 (en) | 2005-05-02 | 2006-04-21 | Novel crystalline forms of tiotropium bromide |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008540366A JP2008540366A (ja) | 2008-11-20 |
| JP2008540366A5 true JP2008540366A5 (enExample) | 2009-06-18 |
| JP5227790B2 JP5227790B2 (ja) | 2013-07-03 |
Family
ID=36693210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008509408A Expired - Lifetime JP5227790B2 (ja) | 2005-05-02 | 2006-04-21 | 新規結晶性臭化チオトロピウム |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7879871B2 (enExample) |
| EP (2) | EP2085396A3 (enExample) |
| JP (1) | JP5227790B2 (enExample) |
| KR (1) | KR20080012932A (enExample) |
| CN (1) | CN101166738B (enExample) |
| AR (1) | AR053599A1 (enExample) |
| AU (1) | AU2006243238B2 (enExample) |
| BR (1) | BRPI0609295A2 (enExample) |
| CA (1) | CA2606549A1 (enExample) |
| DK (1) | DK1881980T3 (enExample) |
| ES (1) | ES2393794T3 (enExample) |
| IL (1) | IL187055A (enExample) |
| MX (1) | MX2007013142A (enExample) |
| NZ (1) | NZ563596A (enExample) |
| PE (1) | PE20061438A1 (enExample) |
| PL (1) | PL1881980T3 (enExample) |
| PT (1) | PT1881980E (enExample) |
| RU (1) | RU2417224C2 (enExample) |
| SI (1) | SI1881980T1 (enExample) |
| TW (1) | TWI392674B (enExample) |
| UY (1) | UY29506A1 (enExample) |
| WO (1) | WO2006117299A2 (enExample) |
| ZA (1) | ZA200708048B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008530251A (ja) * | 2005-12-19 | 2008-08-07 | シコール インコーポレイティド | 純粋且つ安定な臭化チオトロピウム |
| PT1869035E (pt) | 2005-12-19 | 2013-01-10 | Sicor Inc | Novas formas de brometo de tiotrópio e processos para sua preparação |
| US9108962B2 (en) | 2005-12-19 | 2015-08-18 | Sicor, Inc. | Forms of tiotropium bromide and processes for preparation thereof |
| CN100999521B (zh) * | 2006-01-13 | 2010-12-08 | 江苏正大天晴药业股份有限公司 | 结晶性抗胆碱药噻托溴铵 |
| US20080051582A1 (en) | 2006-07-10 | 2008-02-28 | Sicor Inc. | Process for the preparation of tiotropium bromide |
| EP1923393A1 (en) * | 2006-11-17 | 2008-05-21 | Boehringer Ingelheim Pharma GmbH & Co. KG | Crystalline form of tiotropium bromide and urea |
| GB0716026D0 (en) * | 2007-08-16 | 2007-09-26 | Norton Healthcare Ltd | An inhalable medicament |
| WO2009087419A1 (en) * | 2008-01-10 | 2009-07-16 | Generics [Uk] Limited | Novel process for the preparation of scopine esters |
| AU2009312582B2 (en) * | 2008-11-04 | 2014-03-27 | Cipla Limited | Tiotropium bromide having a low degree of crystallinity |
| BRPI0916047A2 (pt) * | 2008-11-04 | 2015-11-10 | Cipla Ltd | composição farmacêutica em aerossol, uso de uma composição farmacêutica em aerossol, método para tratamento de sintomas crônicos ou agudos severos, moderados ou leves, ou para tratamento profilático de um distúrbio respiratório, dispensador farmacêutico em aerossol, processo para fabricação de um dispensador farmacêutico em aerossol e processo para fabricação de um complexo de um agente ativo e um adjuvante |
| EP2403851B1 (en) | 2009-03-06 | 2015-06-17 | Mahmut Bilgic | New crystalline forms of tiotropium bromide |
| CA2768553C (en) | 2009-08-07 | 2016-08-02 | Generics [Uk] Limited | Anhydrate of tiotropium bromide |
| WO2011015883A1 (en) | 2009-08-07 | 2011-02-10 | Generics [Uk] Limited | Dichloromethane solvate of tiotropium bromide and its use |
| TR201007108A2 (tr) * | 2010-08-25 | 2012-03-21 | B�Lg�� Mahmut | Yeni tiotropyum bromür kristali ve üretim yöntemi.@ |
| TR201102068A2 (tr) | 2011-03-03 | 2012-09-21 | Bi̇lgi̇ç Mahmut | Tiotropyum bromür içeren kristal maddeler |
| TR201111589A2 (tr) * | 2011-03-03 | 2012-09-21 | Bi̇lgi̇ç Mahmut | Tiotropyum bromür susuz kristal formu. |
| CZ304368B6 (cs) | 2011-11-28 | 2014-04-02 | Zentiva, K.S. | Směsný solvát tiotropium bromidu a způsob jeho přípravy |
| GB201200525D0 (en) | 2011-12-19 | 2012-02-29 | Teva Branded Pharmaceutical Prod R & D Inc | An inhalable medicament |
| PT106142B (pt) | 2012-02-10 | 2014-07-18 | Hovione Farmaci Ncia S A | Processo para a preparação de brometo de tiotrópio |
| EP2897955B1 (en) * | 2012-09-11 | 2019-11-06 | Bilgic, Mahmut | New tiotropium bromide crystalline form |
| ES2620758T3 (es) | 2012-11-05 | 2017-06-29 | Zentiva K.S. | Estabilización de solvatos de tiotropio |
| KR20150135328A (ko) | 2013-04-01 | 2015-12-02 | 풀매트릭스 인코퍼레이티드 | 티오트로피움 건조 분말 |
| EP2913332A1 (en) | 2014-02-27 | 2015-09-02 | Euticals S.P.A. | Crystalline form of tiotropium bromide with lactose |
| US10034866B2 (en) | 2014-06-19 | 2018-07-31 | Teva Branded Pharmaceutical Products R&D, Inc. | Inhalable medicament comprising tiotropium |
| WO2017138896A1 (en) * | 2016-02-11 | 2017-08-17 | Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti | Crystalline form of tiotropium bromide anhydrate |
| PT115583B (pt) | 2019-06-17 | 2022-05-02 | Hovione Farm S A | Processo contínuo para a preparação de medicamentos anticolinérgicos |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB845056A (en) | 1957-07-05 | 1960-08-17 | Egyt Gyogyszervegyeszeti Gyar | Improvements in or relating to tropane derivatives |
| DE1166787B (de) | 1960-07-09 | 1964-04-02 | Boehringer & Soehne Gmbh | Verfahren zur Herstellung von neuen Granatanol-(3ª‰)-estern und ihren Hydrohalogeniden |
| GB955535A (en) | 1962-10-22 | 1964-04-15 | Boehringer & Soehne Gmbh | New n-substituted norgranatanol-(3ª‰)-esters |
| DE2046659A1 (enExample) | 1970-01-28 | 1972-03-23 | ||
| US3808263A (en) * | 1970-05-12 | 1974-04-30 | Tanabe Seiyaku Co | 6,6-dimethyl-9-alkyl-9-azabicyclo(3.3.1)nonan-3-ols |
| US3673195A (en) * | 1970-05-25 | 1972-06-27 | Tanabe Seiyaku Co | Derivatives of 6,6,9-tri-lower alkyl-9-azabicyclo(3.3.1) nonan-3{60 -or 3{62 -ol |
| US4353922A (en) * | 1981-03-13 | 1982-10-12 | Syntex (U.S.A.) Inc. | Anticholinergic bronchodilators |
| US4570630A (en) | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
| AU591152B2 (en) | 1985-07-30 | 1989-11-30 | Glaxo Group Limited | Devices for administering medicaments to patients |
| DE3546218A1 (de) * | 1985-12-27 | 1987-07-02 | Madaus & Co Dr | Azoniaspironortropanolester, verfahren zu deren herstellung und pharmazeutisches mittel |
| US5610163A (en) * | 1989-09-16 | 1997-03-11 | Boehringer Ingelheim Gmbh | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
| DE3931041C2 (de) | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| US5770738A (en) * | 1992-03-05 | 1998-06-23 | Boehringer Ingelheim Kg | Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions |
| ES2129117T3 (es) | 1992-12-09 | 1999-06-01 | Boehringer Ingelheim Pharma | Formulaciones en disolucion en forma de aerosol medicinales estabilizadas. |
| DE4318455A1 (de) | 1993-06-03 | 1994-12-08 | Boehringer Ingelheim Kg | Kapselhalterung |
| ATE234604T1 (de) | 1998-08-04 | 2003-04-15 | Jago Res Ag | Medizinische aerosolformulierungen |
| DE19921693A1 (de) * | 1999-05-12 | 2000-11-16 | Boehringer Ingelheim Pharma | Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika |
| US6908928B2 (en) * | 2000-10-12 | 2005-06-21 | Bi Pharma Kg. | Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions |
| AP1712A (en) | 2000-10-12 | 2007-01-24 | Boehringer Ingelheim Pharma | Novel tiotropium-containing inhalation powder |
| UA75375C2 (en) | 2000-10-12 | 2006-04-17 | Boehringer Ingelheim Pharma | Method for producing powdery preparations for inhaling |
| AU2002214996B2 (en) | 2000-10-12 | 2007-03-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament |
| US20020111363A1 (en) * | 2000-10-31 | 2002-08-15 | Karin Drechsel | Inhalable formulation of a solution containing a tiotropium salt |
| EA007604B1 (ru) | 2000-10-31 | 2006-12-29 | Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг | Ингаляционная композиция в виде раствора с солью тиотропия |
| US20020193392A1 (en) * | 2000-11-13 | 2002-12-19 | Christel Schmelzer | Pharmaceutical compositions based on tiotropium salts of salts of salmeterol |
| DE10056104A1 (de) | 2000-11-13 | 2002-05-23 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols |
| DE10064816A1 (de) | 2000-12-22 | 2002-06-27 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung eines Anticholinergikums |
| US6506900B1 (en) * | 2001-01-31 | 2003-01-14 | Boehringer Ingelheim Pharma Ag | Process for preparing a scopine ester intermediate |
| DE10111843A1 (de) | 2001-03-13 | 2002-09-19 | Boehringer Ingelheim Pharma | Verbindungen zur Behandlung von inflammatorischen Erkrankungen |
| US20020193394A1 (en) * | 2001-03-13 | 2002-12-19 | Bernd Disse | Compounds for treating inflammatory diseases |
| US6608055B2 (en) * | 2001-06-22 | 2003-08-19 | Boehringer Ingelheim Pharma Kg | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition |
| CA2450961C (en) * | 2001-06-22 | 2010-03-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition |
| GB0118373D0 (en) * | 2001-07-27 | 2001-09-19 | Glaxo Group Ltd | Novel therapeutic method |
| DE10200943A1 (de) * | 2002-01-12 | 2003-07-24 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Scopinestern |
| US20030229227A1 (en) * | 2002-03-16 | 2003-12-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New difurylglycolic acid esters, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions |
| DE10212264A1 (de) | 2002-03-20 | 2003-10-02 | Boehringer Ingelheim Pharma | Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels |
| US7309707B2 (en) * | 2002-03-20 | 2007-12-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament |
| DE10214264A1 (de) * | 2002-03-28 | 2003-10-16 | Boehringer Ingelheim Pharma | HFA-Suspensionsformulierungen eines Anhydrats |
| US7244415B2 (en) * | 2002-03-28 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | HFA suspension formulations of an anhydrate |
| US7311894B2 (en) * | 2002-03-28 | 2007-12-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | HFA suspension formulations containing an anticholinergic |
| AU2003303029A1 (en) * | 2002-12-16 | 2004-07-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tiotropium containing hfc solution formulations |
| US7968717B2 (en) * | 2003-11-03 | 2011-06-28 | Boehringer Ingelhein International Gmbh | Crystalline anhydrate with anticholinergic efficacy |
| DE102004041253A1 (de) * | 2004-08-26 | 2006-03-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neues Verfahren zur Herstellung von Tiotropiumsalzen |
-
2006
- 2006-04-21 KR KR1020077028139A patent/KR20080012932A/ko not_active Ceased
- 2006-04-21 JP JP2008509408A patent/JP5227790B2/ja not_active Expired - Lifetime
- 2006-04-21 CN CN2006800142275A patent/CN101166738B/zh not_active Expired - Lifetime
- 2006-04-21 AU AU2006243238A patent/AU2006243238B2/en not_active Ceased
- 2006-04-21 PL PL06754794T patent/PL1881980T3/pl unknown
- 2006-04-21 ES ES06754794T patent/ES2393794T3/es not_active Expired - Lifetime
- 2006-04-21 PT PT67547943T patent/PT1881980E/pt unknown
- 2006-04-21 RU RU2007144521/04A patent/RU2417224C2/ru active
- 2006-04-21 NZ NZ563596A patent/NZ563596A/en not_active IP Right Cessation
- 2006-04-21 CA CA002606549A patent/CA2606549A1/en not_active Abandoned
- 2006-04-21 BR BRPI0609295-0A patent/BRPI0609295A2/pt not_active IP Right Cessation
- 2006-04-21 EP EP09157096A patent/EP2085396A3/en not_active Withdrawn
- 2006-04-21 SI SI200631474T patent/SI1881980T1/sl unknown
- 2006-04-21 WO PCT/EP2006/061763 patent/WO2006117299A2/en not_active Ceased
- 2006-04-21 EP EP06754794A patent/EP1881980B1/en not_active Expired - Lifetime
- 2006-04-21 DK DK06754794.3T patent/DK1881980T3/da active
- 2006-04-28 AR ARP060101714A patent/AR053599A1/es unknown
- 2006-04-28 PE PE2006000456A patent/PE20061438A1/es not_active Application Discontinuation
- 2006-04-28 UY UY29506A patent/UY29506A1/es not_active Application Discontinuation
- 2006-04-28 TW TW095115408A patent/TWI392674B/zh not_active IP Right Cessation
- 2006-05-01 US US11/381,076 patent/US7879871B2/en active Active
- 2006-12-07 MX MX2007013142A patent/MX2007013142A/es active IP Right Grant
-
2007
- 2007-09-19 ZA ZA200708048A patent/ZA200708048B/xx unknown
- 2007-10-31 IL IL187055A patent/IL187055A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2007144521A (ru) | Новые кристаллические формы тиотропийбромида | |
| JP2008540367A5 (enExample) | ||
| CN101412700B (zh) | 非布司他的晶型及其制备方法 | |
| BR112020014487A2 (pt) | composições farmacêuticas para tratamento de fi-brose cística | |
| KR20120120453A (ko) | Ｎ4-(2,2-다이플루오로-4ｈ-벤조〔1,4〕옥사진-3-온)-6-일〕-5-플루오로-ｎ2-〔3-(메틸아미노카보닐메틸렌옥시)페닐〕2,4-피리미딘다이아민의 지나포에이트 염 | |
| AU2004226824A1 (en) | Quinoline-2-one-derivatives for the treatment of airways diseases | |
| JP2000516932A (ja) | 新規のベンゾフラン―４―カルボキサミド | |
| BRPI0713590A2 (pt) | derivados de pirrol com atividade de modulador de receptor de crth2 | |
| JP2013540810A (ja) | １−｛（２Ｓ）−２−アミノ−４−［２，４−ビス（トリフルオロメチル）−５，８−ジヒドロピリド［３，４−ｄ］ピリミジン−７（６Ｈ）−イル］−４−オキソブチル｝−５，５−ジフルオロピペリジン−２−オン酒石酸塩の水和物 | |
| CN104797580A (zh) | 阿哌沙班的晶型或无定形及其制备工艺 | |
| CN103965116A (zh) | 半5-氟胞嘧啶盐、其制备方法及应用 | |
| TR201900735T4 (tr) | Yeni kaynaşık imidazobenzotiyazol bileşikleri. | |
| PT1651641E (pt) | Derivados de nicotinamida úteis como inibidores de pde4. | |
| CN102746276B (zh) | 一种艾普拉唑钠晶型及其制备方法 | |
| RU2012154006A (ru) | Кристаллическая форма гликопиррония хлорида | |
| CN103588457B (zh) | 低密度保温石膏板及其制备方法 | |
| JP2009508874A (ja) | イリノテカン塩酸塩の新規結晶形 | |
| JP2018508549A5 (enExample) | ||
| US8003700B2 (en) | Colchicine solid complex; methods of making; and methods of use thereof | |
| JP2021512941A (ja) | メサコニンの結晶形およびその調製方法 | |
| CN104610232B (zh) | 阿利沙坦酯无定形及其制备方法及含所述无定形的药物组合物 | |
| CN103204843B (zh) | 结晶型艾普拉唑钠乙醇化物及其制备方法 | |
| JP2010540440A5 (enExample) | ||
| JPH05213934A (ja) | ピラゾール誘導体 | |
| CN115501186A (zh) | 一种黄酮醇糖苷-柠檬酸固体分散体及其制备方法 |